HNRNPA2B1 and breast cancer: We used miRNA-seq to identify differences in miRNA transcripts in MCF-7 cells when HNRNPA2/B1 is overexpressed and evaluated the pathways and mRNA targets associated with each misregulated miRNA for relevance to breast cancer and endocrine resistance.